Free shipping on all orders over $ 500

Glucosylceramide synthase-IN-1 

Cat. No. M29724

All AbMole products are for research use only, cannot be used for human consumption.

Glucosylceramide synthase-IN-1  Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Glucosylceramide synthase-IN-1 (T-036) a potent, brain-penetrant and orally active glucosylceramide synthase (GCS) inhibitor with IC50s of 31 nM and 51 nM for human GCS and mouse GCS, respectively. Glucosylceramide synthase-IN-1 can be used for Gaucher's disease research.

Chemical Information
Molecular Weight 460.42
Formula C24H20F4N2O3
CAS Number 2601393-20-6
Form Solid
Solubility (25°C) DMSO 100 mg/mL (ultrasonic)
Storage 4°C, protect from light, dry, sealed
References

[1] Liping Wang, et al. Sci Adv. Neuronal activity induces glucosylceramide that is secreted via exosomes for lysosomal degradation in glia

[2] Ivan Milenkovic, et al. Curr Opin Neurobiol. GBA mutations, glucosylceramide and Parkinson's disease

[3] Jian Gan, et al. Acta Biochim Pol. The role of glucosylceramide and glucosylceramide synthase in liver disease: from bench to bedside - Review

[4] Maria C Messner, et al. Adv Exp Med Biol. Glucosylceramide in humans

[5] Richard J Bleicher, et al. Biochim Biophys Acta. Glucosylceramide synthase and apoptosis

Related Glucosylceramide Synthase Products
DL-threo-PDMP hydrochloride 

DL-threo-PDMP hydrochloride is the hydrochloride form of DL-threo-PDMP that is a competitive glucosylceramide synthase (GCS) inhibitor.

G43

G43 is a potent, selective glucosyltransferase inhibitor, with the Kd of 3.7μM and 46.9 nM for GtfB and GtfC, respectively.

D-threo-PDMP 

D-threo-PDMP is a potent glucoceramide synthase (GCS) inhibitor, which reduces the glycosphingolipids on the cell surface by inhibiting glycosylation, reduces the total length of the axon plexus and the number of axon branch points, and inhibits neurite growth.

Lucerastat

Lucerasta is the galactose form of Miglustat, an orally active inhibitor of glucosylceramide synthase (GCS).Lucerastat has potential for use in Fabry disease research.

Glucosylceramide synthase-IN-2

Glucosylceramide-IN-2 (T-690) is a potent, blood-brain barrier-transparent and orally active inhibitor of glucosylceramide synthase (GCS) with IC50s of 15 nM and 190 nM for human GCS and mouse GCS, respectively. basal and non-competitive with UDP-glucose.

  Catalog
Abmole Inhibitor Catalog




Keywords: Glucosylceramide synthase-IN-1  supplier, Glucosylceramide Synthase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.